Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/13/2014US20140045874 Prevention of alcohol reaction with dietary supplements
02/13/2014US20140045872 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
02/13/2014US20140045863 Muscarinic Agonists as Cognitive Enhancers
02/13/2014US20140045858 Compound preparation treating alzheimer's disease and preparation method thereof
02/13/2014US20140045853 Materials, methods, and systems for treating cancer
02/13/2014US20140045847 Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
02/13/2014US20140045843 Methods of treating cancer using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
02/13/2014US20140045841 Method for inhibiting the growth of cancer stem cell
02/13/2014US20140045838 Kinase inhibitors and method of treating cancer
02/13/2014US20140045837 9-Substituted 8-Oxoadenine Compound
02/13/2014US20140045831 Bicyclic heterocycle compounds and their uses in therapy
02/13/2014US20140045823 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
02/13/2014US20140045822 Kinase inhibitors and method of treating cancer with same
02/13/2014US20140045818 Benzothiazole compounds and their pharmaceutical use
02/13/2014US20140045809 Corroles for neuroprotection and neurorescue
02/13/2014US20140045807 The use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury
02/13/2014US20140045806 Sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
02/13/2014US20140045805 Fragrance Compositions and Other Compositions Which Contain Naturally Occurring Substances Found in Corals
02/13/2014US20140045804 Treatment of hypoactive sexual disorder (hsdd)
02/13/2014US20140045803 Ophthalmic Formulations Of Cetirizine And Methods Of Use
02/13/2014US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/13/2014US20140045801 Pramipexole transdermal delivery for severe headaches
02/13/2014US20140045800 Tetracyclic inhibitors of fatty acid amide hydrolase
02/13/2014US20140045796 Transient hypoxia inducers and their use
02/13/2014US20140045795 Compounds for the treatment of proliferative disorders
02/13/2014US20140045794 Phosphonate Compounds
02/13/2014US20140045792 Intravaginal ring comprising polyurethane composition for drug delivery
02/13/2014US20140045791 Combination therapy to treat mycobacterium diseases
02/13/2014US20140045790 Novel Bicyclic Pyridinones
02/13/2014US20140045788 Method of stably treating incontinence using a bulking agent
02/13/2014US20140045787 Hypertonic Dextran Solution and Methods of Treating and Preventing Recurrent Corneal Erosion
02/13/2014US20140045786 Hypertonic Dextran Solution and Methods of Treating and Preventing Recurrent Corneal Erosion
02/13/2014US20140045785 Anti-inflammatory effect of microfibrillated cellulose
02/13/2014US20140045784 Glycosaminoglycan Composition and Method for Treatment and Prevention of Interstitial Cystitis
02/13/2014US20140045783 Nucleoside phosphoramidate prodrugs
02/13/2014US20140045782 Method of treatment using checkpoint kinase 1 inhibitors
02/13/2014US20140045780 Compositions comprising spicamycin derivatives and methods of use thereof
02/13/2014US20140045779 Compounds containing an alicyclie structure and anti-tumor application
02/13/2014US20140045774 Methods for treating viral disorders
02/13/2014US20140045773 Ophthalmic compositions and methods for treating eyes
02/13/2014US20140045765 Method for inhibiting autophagy of motor neurons
02/13/2014US20140045762 Molecular switch for neuronal outgrowth
02/13/2014US20140045758 Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock
02/13/2014US20140045752 Multicomponent compositions and the uses
02/13/2014US20140045746 Antidiabetic tricyclic compounds
02/13/2014US20140045407 Composition and method for improving survival of bee colonies
02/13/2014US20140044813 Plant Extracts for Improving Cognitive Health and Function
02/13/2014US20140044809 Antacid formulations and associated methods
02/13/2014US20140044806 New positive allosteric modulators of nicotinic acetylcholine receptor
02/13/2014US20140044803 Method of using flibanserin for neuroprotection
02/13/2014US20140044802 Compounds useful as inhibitors of atr kinase and combination therapies thereof
02/13/2014US20140044799 Molecular signature of cutaneous pigmentary spots, associated with the organization of the extracellular matrix
02/13/2014US20140044797 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
02/13/2014US20140044789 Melanin nanoshells for protection against radiation and electronic pulses
02/13/2014US20140044788 Solid Oral Formulations of a Pyridopyrimidinone
02/13/2014US20140044787 Controlled release pharmaceutical compositions
02/13/2014US20140044786 Once-weekly oral administration of aripiprazole
02/13/2014US20140044784 Combined formulation with improved stability
02/13/2014US20140044783 Pharmaceutical composition comprising a thiazolidinedione
02/13/2014US20140044782 Controlled release formulations of opioid and nonopioid analgesics
02/13/2014US20140044781 Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
02/13/2014US20140044780 Extended-Release Levetiracetam and Method of Preparation
02/13/2014US20140044777 Liposome Composition
02/13/2014US20140044757 Method for selectively inhibiting acat1 in the treatment of alzheimer's disease
02/13/2014US20140044755 RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF KRAS GENE
02/13/2014US20140044741 B-type plexin antagonists and uses thereof
02/13/2014US20140044737 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
02/13/2014US20140044736 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
02/13/2014US20140044710 Von willebrand factor specific binders and methods of use therefor
02/13/2014US20140044709 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1
02/13/2014US20140044706 Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
02/13/2014US20140044705 Combination therapy of an afucosylated cd20 antibody with bendamustine
02/13/2014US20140044704 Treatment of metastatic breast cancer
02/13/2014US20140044702 Diagnosis and treatments relating to th2 inhibition
02/13/2014US20140044693 Oxidative retinal diseases
02/13/2014US20140044692 Impaired energy processing disorders and mitochondrial deficiency
02/13/2014US20140044690 High-Energy Compounds for Use in Alzheimer's and Other Neurodegenerative Diseases
02/13/2014US20140044685 Nutritional compositions having alpha-hica and citrulline
02/13/2014US20140044684 Methods And Compositions For Regulating Gene Expression
02/13/2014US20140044683 Cell fusion promoter and utilization of the same
02/13/2014US20140044671 Amine condensation polymers as phosphate sequestrants
02/13/2014US20140044670 Skin compositions and methods of use thereof
02/13/2014US20140044669 Cyclodextrin-based polymers for therapeutics delivery
02/13/2014US20140044667 Healing composition for topical application
02/13/2014US20140044652 Methods and Related Systems for Selecting or Customizing a Topical Treatment Regimen for a Mammalian Keratinized Surface
02/13/2014US20140044646 Labeled, Non-Peptidic, Multivalent Integrin Antagonist Compounds; Methods for Synthesis and Uses Thereof
02/13/2014US20140044644 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
02/13/2014US20140044640 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
02/13/2014US20140044639 Antibody Therapy
02/13/2014US20140042654 Fulvestrant nanosphere/microsphere and preparative method and use thereof
02/13/2014US20140042051 Pharmaceutical foam
02/13/2014DE102012214038A1 Verwendung von Wirkstoffkombinationen aus Harnstoff und Car-ni-tin und/oder einem oder mehreren Acyl-Carnitinen zur Behandlung und Prophylaxe von Neurodermitis sowie des diabetischen Fußes Use of active compound combinations of urea and car-ni-tin and / or one or more acyl carnitines for the treatment and prophylaxis of atopic dermatitis and the diabetic foot
02/13/2014DE102010006245B4 Mayamycin-Verbindungen, Verfahren zu deren Herstellung, deren Verwendungen und diese enthaltendes kosmetisches Produkt Mayamycin compounds, processes for their preparation, their uses and these cosmetic product containing
02/13/2014DE102009022414B4 Antibakterielle Verwendung eines Extrakts aus Morus australis Poir. Antibacterial use of an extract of Morus australis Poir. und der Verbindung Kuwanon H and the connection Kuwanon H
02/12/2014EP2695942A1 microRNAs in therapy and diagnostic of cancer
02/12/2014EP2695884A1 Camptothecin derivatives having anti-tumor activity
02/12/2014EP2695883A2 Tricyclic derivatives of n,n'-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon
02/12/2014EP2695881A1 Guanidine compound
02/12/2014EP2695874A1 Myrtucommulone analogues
02/12/2014EP2695621A1 Pharmaceutical preparation
1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 7860